Performance of BCAB Bioatla Inc | -15.4% in 12m
Compare BCAB with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Bioatla Inc with its related Sector/Index XBI
Performance Duell BCAB vs XBI
| TimeFrame | BCAB | XBI |
|---|---|---|
| 1 Day | -8.71% | -1.52% |
| 1 Week | 7.20% | 1.45% |
| 1 Month | 34.4% | 10.08% |
| 3 Months | 17.4% | -1.30% |
| 6 Months | 69.5% | 24.09% |
| 12 Months | -15.4% | 6.83% |
| YTD | 6.79% | 1.05% |
| Rel. Perf. 1m | 0.46 | |
| Rel. Perf. 3m | 1.36 | |
| Rel. Perf. 6m | 3.41 | |
| Rel. Perf. 12m | -2.48 |
Is Bioatla Inc a good stock to buy?
No, based on ValueRay Fundamental Analyses, Bioatla Inc (NASDAQ:BCAB) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -89.99 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BCAB as of May 2024 is 2.57. This means that BCAB is currently overvalued and has a potential downside of -9.19% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BCAB as of May 2024 is 2.57. This means that BCAB is currently overvalued and has a potential downside of -9.19% (Sold with Premium).
Is BCAB a buy, sell or hold?
- Strong Buy: 2
- Buy: 3
- Hold: 0
- Sell: 0
- Strong Sell: 0
Values above 0%: BCAB is performing better - Values below 0%: BCAB is underperforming
Compare BCAB with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5.56% | 27.51% | 52.07% | -43.71% |
| US NASDAQ 100 | QQQ | 5.24% | 25.49% | 53.40% | -50.55% |
| US Dow Jones Industrial 30 | DIA | 5.81% | 28.98% | 54.68% | -37.31% |
| German DAX 40 | DBXD | 7.44% | 29.29% | 52.30% | -29.78% |
| UK FTSE 100 | ISFU | 5.66% | 24.89% | 53.22% | -30.05% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 6.05% | 29.71% | 67.34% | -8.12% |
| Hongkong Hang Seng | HSI | 5.05% | 11.58% | 65.77% | -9.99% |
| Japan Nikkei 225 | EXX7 | 6.14% | 33.56% | 57.68% | -26.13% |
| India NIFTY 50 | INDA | 4.78% | 31.24% | 51.88% | -45.22% |
| Brasil Bovespa | EWZ | 7.29% | 31.15% | 73.22% | -28.11% |
BCAB Bioatla Inc vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.01% | 30.49% | 52.28% | -51.18% |
| Consumer Discretionary | XLY | 6.73% | 29.17% | 62.67% | -34.23% |
| Consumer Staples | XLP | 6.15% | 29.38% | 55.14% | -21.43% |
| Energy | XLE | 5.73% | 34.45% | 55.50% | -38.76% |
| Financial | XLF | 5.21% | 29.21% | 47.53% | -48.06% |
| Health Care | XLV | 5.21% | 29.14% | 55.15% | -28.65% |
| Industrial | XLI | 7.06% | 30.41% | 50.13% | -43.11% |
| Materials | XLB | 6.80% | 30.85% | 53.64% | -35.00% |
| Real Estate | XLRE | 4.96% | 26.41% | 60.66% | -26.26% |
| Technology | XLK | 4.63% | 24.42% | 54.80% | -51.00% |
| Utilities | XLU | 5.70% | 23.88% | 50.90% | -28.59% |
| Aerospace & Defense | XAR | 6.13% | 26.08% | 55.21% | -39.83% |
| Biotech | XBI | 5.75% | 24.36% | 45.37% | -22.23% |
| Homebuilder | XHB | 6.62% | 27.44% | 39.20% | -66.25% |
| Retail | XRT | 7.68% | 27.75% | 49.36% | -44.90% |
Does Bioatla Inc outperform its market, is BCAB a Sector Leader?
No, over the last 12 months Bioatla Inc (BCAB) made -15.40%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.83%.
Over the last 3 months BCAB made 17.43%, while XBI made -1.30%.
No, over the last 12 months Bioatla Inc (BCAB) made -15.40%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.83%.
Over the last 3 months BCAB made 17.43%, while XBI made -1.30%.
| Period | BCAB | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 34.44% | 10.08% | 6.93% |
| 3 Months | 17.43% | -1.30% | 6.91% |
| 12 Months | -15.40% | 6.83% | 28.31% |